Dose-Dependent Effects of Methadone on QT interval in Patients under Methadone Maintenance Treatment

سال انتشار: 1392
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 278

متن کامل این مقاله منتشر نشده است و فقط به صورت چکیده یا چکیده مبسوط در پایگاه موجود می باشد.
توضیح: معمولا کلیه مقالاتی که کمتر از ۵ صفحه باشند در پایگاه سیویلیکا اصل مقاله (فول تکست) محسوب نمی شوند و فقط کاربران عضو بدون کسر اعتبار می توانند فایل آنها را دریافت نمایند.

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_PJMT-2-1_002

تاریخ نمایه سازی: 23 مهر 1398

چکیده مقاله:

Background: The role of methadone in QTc prolongation, Torsades de Pointes (TdP) arrhythmia and sudden cardiac death has been debated. Because of widespread use of methadone in methadone maintenance treatment (MMT) centers, we aimed to study dose-related effects of methadone on QTc prolongation. Methods: In a comparative observational study, 90 patients who were under MMT were evaluated. Patients were divided into three groups according to methadone daily dose (G1: 0-59 mg, G2: 60-109 mg, G3: 110-150 mg). Twelve-lead electrocardiograms (ECG) were performed at baseline and two months later, after reaching the maximum daily dose of methadone. The QTc were calculated for each patient. Comparison of mean QTc and mean QTc prolongation between baseline and follow up ECGs were analyzed. Results: In total, mean (SD) age was 32.4 (8.5). TdP was not detected in any patients. Mean QTc was 405.2 (17.0) and 418.5 (23.1) msec before and two months after MMT respectively. There was a significant difference between mean QTc in each group before and after treatment (P<0.001). In total, mean QTc prolongation was 13.5 (8.1). Univariate analysis showed that there was a significant difference in means of QTc prolongation between G1 and the other two groups (P=0.001), but not between G2 and G3. This indicates that patients receiving methadone over 60 mg/day are at a risk of greater QTc prolongation. Conclusion: Methadone can cause QTc prolongation in different doses. However, the extent of this effect is dose dependent. Daily dose of less than 60 mg methadone is a safer cardiac dose. Nevertheless, it is not possible to administer this low dose for all opioid addict patients. Therefore, it is necessary to closely monitor patients under MMT, especially those receiving higher methadone doses, with constant scheduled ECGs before and during treatment.

نویسندگان

Farzad Gheshlaghi

Department of Clinical Toxicology and Forensic Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Nastaran Izadi-Mood

Department of Clinical Toxicology and Forensic Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran. Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

Armin Mardani

Addiction Research Centre, Mashhad University of Medical Sciences, Mashhad, Iran.

Mohammad Piri-Ardekani

Isfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Layson-Wolf C, Goode JV, Small RE. Clinical use of methadone. ...
  • Methadone in maintenance treatment of narcotic addicts; joint revision of ...
  • Nelson LS, Olsen D. Opioids. In: Nelson LS, Lewin NA, ...
  • Schmittner J, Krantz MJ. QTc prolongation in methadone maintenance: Fact ...
  • Cruciani RA. Methadone: to ECG or not to ECG...That is ...
  • Gil M, Sala M, Anguera I, Chapinal O, Cervantes M, ...
  • Decerf JA, Gressens B, Brohet C, Liolios A, Hantson P. ...
  • Krantz MJ, Mehler PS. Methadone and QT prolongation: a dose-dependent ...
  • Martell BA, Arnsten JH, Ray B, Gourevitch MN. The impact ...
  • Roden DM. Drug-induced prolongation of the QT interval. N Engl ...
  • Krantz MJ, Mehler PS. QTc prolongation: methadone s efficacy-safety paradox. ...
  • Katchman AN, McGroary KA, Kilborn MJ, et al. Influence of ...
  • Krantz MJ, Martin J, Stimmel B, Mehta D, Haigney MC. ...
  • Routhier DD, Katz KD, Brooks DE. QTc prolongation and torsades ...
  • Kornick CA, Kilborn MJ, Santiago-Palma J, Schulman G, Thaler HT, ...
  • Liu BA, Juurlink DN. Drugs and the QT interval - ...
  • Chatterjee B, Bürgi U. Syncope of a drug addict - ...
  • Krantz MJ, Lewkowiez L, Hays H, Woodroffe MA, Robertson AD, ...
  • Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH. ...
  • Kay GN, Plumb VJ, Arciniegas JG, Henthorn RW, Waldo AL. ...
  • Roden DM, Woosley RL, Primm RK. Incidence and clinical features ...
  • Torp-Pedersen C, Møller M, Bloch-Thomsen PE, Køber L, Sandøe E, ...
  • Houltz B, Darpö B, Edvardsson N, Blomström P, Brachmann J, ...
  • El-Sherif N, Turitto G. Torsade de pointes. Curr Opin Cardiol ...
  • نمایش کامل مراجع